CLL, Refractory
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia (NCT04512105) | University of California, Irvine | 2020-12-02 |
| A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS (NCT03884829) | Cyclacel Pharmaceuticals, Inc. | 2019-03-25 |
Track CLL, Refractory automatically
Every clearance here is in the API, with alerts when new ones post.